在阻塞性睡眠呼吸暂停患者的血压降低中,部进步与CPAP对比
Yi-Hui Ou1, Juliana Tereza Colpani2, Crystal S Cheong3
1Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Journal of the American College of Cardiology
|April 8, 2024
概括
部推进装置 (MAD) 与连续正气道压力 (CPAP) 不逊色,用于降低阻塞性睡眠呼吸暂停 (OSA) 的高血压患者的血压. 这两种治疗都改善了嗜睡,但并没有改善心血管生物标志物.
科学领域:
- 心脏病学 心脏病学
- 睡眠医学 睡眠医学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 高血压指南提倡阻塞性睡眠呼吸暂停 (OSA) 诊断和治疗.
- 部推进装置 (MAD) 为无法使用持续正气道压力 (CPAP) 的患者提供替代口服器械治疗.
研究的目的:
- 为了比较MAD与CPAP在降低24小时门诊血压 (BP) 的有效性.
主要方法:
- 一个随机的非劣势性试验,涉及220名参与者,患有中度至重度的OSA和高血压.
- 参与者被随机分配到MAD或CPAP,主要结果是6个月内24小时平均动脉血压的变化.
主要成果:
- MAD显著降低了24小时平均动脉血压2.5毫米升 (P=0.003),而CPAP没有显著的变化.
- 两组之间的差异有利于MAD (-1.6 mm Hg;非劣势P < 0.001),二次血压参数减少更大,特别是睡眠血压.
- 这两种设备都改善了白天的嗜睡,心血管生物标志物没有差异.
结论:
- MAD是一种与CPAP无劣的治疗方法,用于降低心血管风险增加的高血压患者的24小时平均动脉血压.
- 这些发现支持MAD作为一种有效的替代方案来管理OSA患者的高血压.
相关概念视频
Sleep Apnea
148
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
148
Mechanical Ventilation III: Noninvasive Ventilation
110
Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
Noninvasive Positive-Pressure Ventilation...
110
Measurement of Blood Pressure
924
Assessing blood pressure is a standard procedure executed in virtually all medical environments. The method utilized today was established over a hundred years ago by an innovative Russian doctor, Dr. Nikolai Korotkoff. The soft ticking noise, known as Korotkoff sounds, heard while taking blood pressure readings results from turbulent blood flow within the vessels. The apparatus required for this procedure includes a sphygmomanometer, a blood pressure cuff attached to a gauge, and a...
924
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
199
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
199
Pre-Procedural Guidelines for Assessing Blood Pressure
563
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
563
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
160
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
160


